ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Creatinine as a Marker of Rejection Reversal in Recipients with Post-Treatment Biopsies

A. Jantz, S. Patel, L. Moore, L. Gaber, R. Knight, A. Gaber

The Methodist Hospital, Houston, TX

Meeting: 2013 American Transplant Congress

Abstract number: D1587

Related Abstracts
  • Application of Rejection Reversal as Defined by Efficacy Endpoints in Present Day Renal Transplantation
  • High Creatinine and Advanced Chronic Rejection (CR) Predicts Graft Loss in Non Adherent Kidney Transplant Recipients

It is debatable whether creatinine can serve as a surrogate marker of rejection reversal. The purpose of the current study was to evaluate the change in creatinine following initiation of rejection treatment as it relates to post-treatment renal biopsies. We evaluated 109 first episodes of biopsy proven acute rejection. Of those patients, 42 (39%) had a post-treatment biopsy and were included in the analysis. Post-treatment biopsies were categorized as complete/near complete (i.e. downgraded to borderline) resolution (R) or partial (downgraded by 1 BANFF grade)/persistent (P). Pure-antibody mediated rejections were excluded from the analysis. Mean age was 49±14 years, 60% were male, 55% were Caucasian, 64% were deceased donors, 14% were re-transplants and mean/median time to rejection were 13/8 months. Twenty-five and 17 patients were included in the R and P groups, respectively. Rejection characteristics are shown below. There were more mixed and grade 2 or higher rejection episodes in the P group, but the difference was not significant most likely due to the small number of patients. There was no difference in the percent change in creatinine at any time point between the R and P groups.

Rejection and Creatinine Characteristics
  Complete/Near Partial/Persistent
ACR alone, % 76 53
Mixed, % 24 47
ACR Grade ≥ 2, % 28 47
Day 0 Creatinine, mg/dL* 2.2 3.9
% Creatinine Change on Day 1 103 103
% Creatinine Change on Day 2 104 96
% Creatinine Change on Day 3 103 88
% Creatinine Change on Day 5-7 87 74
% Creatinine Change on Day 10-14 85 70
*p=0.003

Those in the P group had significantly worse graft survival post-rejection when compared to those in the R group (p=0.003).

Therefore, there does not appear to be a correlation between change in creatinine and rejection resolution based on biopsy. This data highlights the importance of post-treatment biopsies to verify rejection resolution.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Jantz A, Patel S, Moore L, Gaber L, Knight R, Gaber A. Creatinine as a Marker of Rejection Reversal in Recipients with Post-Treatment Biopsies [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/creatinine-as-a-marker-of-rejection-reversal-in-recipients-with-post-treatment-biopsies/. Accessed January 17, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.